Pesquisar
Elanco Animal Health Inc
ELANAdicionar à lista de desejos
24.270USD
+0.310+1.29%
Horário de mercado （ET）Cotações atrasadas em 15 min
12.06BValor de mercado
PerdaP/L TTM
Mais detalhes de Elanco Animal Health Inc Empresa
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Informações de Elanco Animal Health Inc
Código da empresaELAN
Nome da EmpresaElanco Animal Health Inc
Data de listagemSep 20, 2018
CEOSimmons (Jeffrey N)
Número de funcionários9000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 20
Endereço450 Elanco Circle
CidadeINDIANAPOLIS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46221
Telefone18773526261
Sitehttps://www.elanco.com/
Código da empresaELAN
Data de listagemSep 20, 2018
CEOSimmons (Jeffrey N)
Executivos da empresa Elanco Animal Health Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Perguntas frequentes
Quem são os cinco principais acionistas de Elanco Animal Health Inc?
Os cinco principais acionistas de Elanco Animal Health Inc são: Mr. Jeffrey N. (Jeff) Simmons
Quantas instituições possuem ações da Elanco Animal Health Inc (ELAN)?
Em 2026Q1, 950 instituições possuíam ações da Elanco Animal Health Inc, com valor de mercado aproximado de 549.30M, representando 109.98% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -60070109.00.
Qual é a maior fonte de receita da Elanco Animal Health Inc?
Em 2026Q1, o segmento de negócios Farm Animal gerou a maior receita para Elanco Animal Health Inc, totalizando 2.36B e representando 50.10% da receita total.
